https://www.selleckchem.com/pr....oducts/lificiguat-yc
In-hospital mortality was higher in patients with rupture (41% vs. 7.40%, p less then 0.001) which remained unchanged over the study period. Hospitalization cost and length of stay was also higher in them. MVP and revascularization led to better survival rates (27.9% vs. 60.6%, adjusted OR 0.14; 95% CI 0.10-0.19; p less then 0.001). Despite significant advancement in the revascularization strategy, PMR/CTR after STEMI continues to portend poor prognosis with high inpatient mortality. Cardiogenic shock is a common presentation an
Like
Comment
Share
